FDA Posts Draft Guidance for Pharma Companies, Sponsors, and Researchers on Using Real-World Data from Health Records in Clinical Studies | Faegre Drinker Biddle & Reath LLP

The U.S. Food and Drug Administration (FDA) has issued a draft guidance for pharmaceutical companies, sponsors, and researchers sourcing Real World Data (RWD) from health records. As...

Related Keywords

,Electronic Health Records ,Framework For Real World Evidence Program ,Faegre Drinker Biddle Reath ,Drug Administration ,Faegre Drinker Biddle ,Real World Data ,Real World Evidence Program ,Real Word Evidence ,Assessing Electronic Health Records ,Biological Products ,Study Design ,Equality Agreement ,Quality Control Plans ,